Contemporary Clinical Trials

Scope & Guideline

Unveiling Insights for Safer Therapeutic Interventions

Introduction

Explore the comprehensive scope of Contemporary Clinical Trials through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Contemporary Clinical Trials in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1551-7144
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2005 to 2024
AbbreviationCONTEMP CLIN TRIALS / Contemp. Clin. Trials
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

Contemporary Clinical Trials focuses on advancing the field of clinical trial methodology and implementation, emphasizing innovative designs and real-world applications to improve health outcomes. The journal aims to publish research that enhances the understanding and performance of clinical trials across diverse populations and health conditions.
  1. Innovative Clinical Trial Designs:
    The journal highlights studies that introduce novel clinical trial designs, such as adaptive trials, platform trials, and hybrid designs, which allow for more flexible and efficient testing of interventions.
  2. Implementation Science:
    A key focus area is on implementation science, examining how interventions can be effectively integrated into real-world healthcare settings to improve patient outcomes.
  3. Patient-Centered Research:
    Contemporary Clinical Trials emphasizes the importance of patient engagement and perspectives in clinical research, aiming to ensure that studies are relevant and beneficial to the populations they serve.
  4. Health Disparities and Equity:
    Research addressing health disparities among various racial and ethnic groups is a significant focus, aiming to improve health equity through targeted interventions and inclusive trial designs.
  5. Digital Health Interventions:
    The journal increasingly publishes studies on digital health interventions, including mobile health applications and telehealth solutions, reflecting the growing importance of technology in healthcare delivery.
  6. Behavioral and Psychosocial Interventions:
    There is a consistent focus on behavioral and psychosocial interventions aimed at improving mental health, chronic disease management, and overall well-being.
Contemporary Clinical Trials is actively engaging with emerging themes that reflect current healthcare challenges and innovations. These trends indicate a dynamic shift in research priorities and methodologies, aligning with contemporary healthcare needs.
  1. Telehealth and Remote Monitoring:
    The increasing emphasis on telehealth interventions and remote monitoring solutions is evident, driven by the need for accessible healthcare options and the lessons learned during the COVID-19 pandemic.
  2. Behavioral Health Interventions:
    There is a growing focus on behavioral health interventions, particularly in the context of chronic disease management and mental health, highlighting their role in improving overall health outcomes.
  3. Health Equity and Diversity:
    An emerging trend is the heightened focus on health equity, with studies designed to address disparities in clinical trial participation and health outcomes among underrepresented populations.
  4. Integration of Artificial Intelligence and Machine Learning:
    The use of artificial intelligence and machine learning in clinical trial design and analysis is gaining traction, indicating a trend towards data-driven methodologies that enhance trial efficiency and effectiveness.
  5. Community-Based Participatory Research (CBPR):
    There is a notable increase in community-based participatory research approaches, which aim to engage communities in the research process and ensure that studies address local health needs and priorities.

Declining or Waning

While Contemporary Clinical Trials has maintained a strong focus on innovative methodologies and health equity, some traditional themes appear to be declining in prominence. This shift may reflect the evolving landscape of clinical research and emerging priorities.
  1. Traditional Randomized Controlled Trials (RCTs) Without Novel Designs:
    There is a noticeable decrease in the publication of studies featuring conventional RCT designs without adaptations or innovative methodologies, as the field moves towards more flexible and adaptive approaches.
  2. Pharmacological Interventions in Isolation:
    Research focusing solely on pharmacological interventions, without consideration of lifestyle modifications or behavioral components, is becoming less common as the journal emphasizes holistic and multifaceted approaches to health.
  3. Single-Site Trials:
    The prevalence of single-site trials appears to be waning, with a shift towards multi-site collaborations that enhance generalizability and participant diversity.
  4. Focus on Established Conditions:
    There is a trend away from studies targeting well-established health conditions in favor of research on emerging health issues and underserved populations, reflecting a shift in research priorities.
  5. Standardized Outcome Measures:
    The journal is moving away from the exclusive use of traditional standardized outcome measures towards more patient-reported outcomes and individualized metrics that reflect the complexities of health experiences.

Similar Journals

JACC-Heart Failure

Advancing the Understanding of Heart Failure
Publisher: ELSEVIER SCI LTDISSN: 2213-1779Frequency: 12 issues/year

JACC-Heart Failure is a premier journal in the field of cardiology, published by Elsevier Science Ltd, that has rapidly established itself as a vital resource for researchers and practitioners focused on heart failure and cardiovascular health. With an impressive impact factor and ranking in the Q1 category for Cardiology and Cardiovascular Medicine, this journal is recognized for its high-quality peer-reviewed articles that contribute significantly to advancements in clinical practice and scientific understanding of heart failure. As of 2023, the journal ranks #10 out of 387 in its field, positioning it in the 97th percentile of Scopus rankings, which highlights its influential role in disseminating cutting-edge research. Although the journal does not operate under an open-access model, it maintains a rigorous review process, ensuring the publication of articles that are both innovative and clinically relevant. Targeting an audience of dedicated researchers, healthcare professionals, and students, JACC-Heart Failure serves as an essential platform for exploring the complexities of heart failure treatments, management strategies, and future directions in cardiology.

Kidney Diseases

Connecting researchers and clinicians for kidney health breakthroughs.
Publisher: KARGERISSN: 2296-9381Frequency: 6 issues/year

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.

BEHAVIORAL MEDICINE

Transforming Health Through Behavioral Insights
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 0896-4289Frequency: 4 issues/year

Behavioral Medicine is a distinguished journal published by Routledge Journals, Taylor & Francis Ltd, specializing in the critical intersection of behavior, health, and disease. Established in 1988, this quarterly academic journal has continually evolved, contributing to the growing understanding of how psychological, behavioral, and social factors impact health outcomes. With an impressive impact factor and consistent categorization in the Q2 quartile for both Applied Psychology and Psychiatry and Mental Health, it stands at the forefront of its field, ranking #182 out of 567 in Psychiatry and #83 out of 249 in Applied Psychology. Behavioral Medicine is committed to advancing research that bridges gaps between psychological theory and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. All articles are accessible in print and online, offering numerous pathways for engagement with this vital field.

NEW ENGLAND JOURNAL OF MEDICINE

Advancing the Frontiers of Medical Knowledge
Publisher: MASSACHUSETTS MEDICAL SOCISSN: 0028-4793Frequency: 52 issues/year

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

Japan Journal of Nursing Science

Transforming Nursing Science for Optimal Patient Outcomes
Publisher: WILEYISSN: 1742-7932Frequency: 4 issues/year

Japan Journal of Nursing Science, published by WILEY, serves as a pivotal resource in the field of nursing, focusing on innovative research and theoretical developments that enhance nursing science practices. With an ISSN of 1742-7932, this journal has established itself as a reputable platform, reflected in its 2023 rankings, which place it in the Q2 category for both Medicine (miscellaneous) and Research and Theory. Covering a broad range of topics crucial to the advancement of nursing, the journal provides researchers, professionals, and students access to high-quality studies, methodologies, and discussions that shape contemporary nursing practices and policies. Though not an Open Access journal, it contributes significantly to the academic discourse and research community, with emphasis on fostering evidence-based practices and promoting excellence in nursing education and healthcare delivery. With a cumulative publishing history from 2006 to the present, the Japan Journal of Nursing Science is committed to disseminating vital knowledge that enriches the nursing profession and improves patient care.

EClinicalMedicine

Unlocking the future of medicine with every publication.
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

EClinicalMedicine, published by Elsevier, is a leading open-access journal that has been championing the field of medicine since its inception in 2018. With a notable impact factor and a commendable ranking of 16th out of 636 in the category of General Medicine, placing it in the 97th percentile, this journal stands as a pivotal resource for the medical community. The journal encompasses an array of topics within the medicine (miscellaneous) category, fostering interdisciplinary collaboration and advancing research that influences clinical practices worldwide. Researchers, professionals, and students alike can benefit from its robust content, enriched by a Q1 quartile classification in 2023, illustrating its high quality and relevance. As an open-access journal, EClinicalMedicine promotes wider dissemination and accessibility of cutting-edge studies, ensuring that critical findings are available to a global audience. Its address in the United Kingdom positions it at the heart of innovative medical research and practice, making it an excellent platform for those at the forefront of health science advancements.

Implementation Science

Transforming evidence into action for better health worldwide.
Publisher: BMCISSN: 1748-5908Frequency: 1 issue/year

Implementation Science is a premier open-access journal published by BMC that has been at the forefront of advancing the field of implementation research since its inception in 2006. With an impressive reputation, this journal has consistently ranked in the Q1 quartile across various categories including Health Informatics, Health Policy, Medicine, and Public Health, reflecting its significant impact and relevance in shaping policy and practice. The journal's robust metrics, including a Scopus rank of #7 in Health Policy and #15 in Public Health, underline its credibility and the high-quality scholarship it publishes. By providing an open access platform, Implementation Science ensures that vital research findings reach a broad audience, facilitating knowledge translation and improving health outcomes on a global scale. Researchers, practitioners, and students engaged in the fields of health services research, policy implementation, and public health will find this journal to be an invaluable resource in their quest for evidence-based solutions.

JAMA Network Open

Transforming evidence into practice for better patient outcomes.
Publisher: AMER MEDICAL ASSOCISSN: 2574-3805Frequency: 12 issues/year

JAMA Network Open is a premier open-access journal published by the American Medical Association, dedicated to advancing the field of medicine through the dissemination of high-quality research. With an ISSN of 2574-3805, this journal has emerged as a vital platform since its launch in 2018, granting unrestricted access to groundbreaking studies and innovative findings in various areas of medicine. Currently boasting an impressive impact factor and ranking in the top 4% (Q1) of General Medicine, JAMA Network Open holds the 23rd position among 636 journals in the medicine category on Scopus, solidifying its status as an influential contributor to the medical community. Aiming to foster collaborative learning and evidence-based practice, the journal attracts submissions from researchers, healthcare professionals, and students alike. By providing a robust forum for research dissemination and engagement, JAMA Network Open plays a crucial role in shaping contemporary medical discourse and enhancing patient care globally.

Addiction Science & Clinical Practice

Empowering research to reshape addiction science.
Publisher: BMCISSN: 1940-0640Frequency: 1 issue/year

Addiction Science & Clinical Practice is a premier open-access journal dedicated to advancing the understanding and treatment of addiction through evidence-based research and clinical practice. Published by BMC in the United Kingdom since 2007, this journal has significantly impacted the fields of Clinical Psychology, Medicine, and Psychiatry and Mental Health, proudly securing a Q1 ranking in multiple categories as of 2023. With an emphasis on high-quality research, the journal provides an inclusive platform for the dissemination of innovative findings and clinical insights that address the complexities of addiction. Researchers, practitioners, and students alike benefit from its unrestricted access since 2012, allowing for widespread dissemination of knowledge. Located at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to lead the way in fostering collaboration and informing best practices in addiction science.

Translational Behavioral Medicine

Unraveling the Complexities of Behavior and Wellness
Publisher: OXFORD UNIV PRESSISSN: 1869-6716Frequency: 4 issues/year

Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.